ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-Rheumatic Drugs Market Research Report 2026
Published Date: 2026-04-15
|
Report Code: QYRE-Auto-14O17385
Home | Market Reports | Health| Health Conditions| Arthritis
Global Anti Rheumatic Drugs Market Research Report 2024
BUY CHAPTERS

Global Anti-Rheumatic Drugs Market Research Report 2026

Code: QYRE-Auto-14O17385
Report
2026-04-15
Pages:137
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
UCB
AbbVie
Bristol–Myers Squibb
Merck
HEYL Chemisch-pharmazeutische Fabrik
Roche
Johnson & Johnson
Amgen Inc
Pfizer Inc
GSK
Sanofi
Abbott Laboratories
Teva Pharmaceutical
Eli Lilly and Company
Celltrion
Astellas Pharma
Simcere
Daiichi Sankyo
Asahi Kasei
Johnson & Johnson

Anti-Rheumatic Drugs Market

The global Anti-Rheumatic Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Anti-rheumatic drugs are medications used to treat rheumatic diseases, which are conditions characterized by inflammation, pain, stiffness, and swelling in the joints, muscles, and other connective tissues. Rheumatic diseases encompass a wide range of conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus (SLE), and juvenile idiopathic arthritis, among others. The goals of treatment with anti-rheumatic drugs are to reduce inflammation, alleviate symptoms, prevent disease progression, and improve overall quality of life for patients.
The North American market for Anti-Rheumatic Drugs is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Anti-Rheumatic Drugs is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Anti-Rheumatic Drugs in Hospital Pharmacies is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Anti-Rheumatic Drugs include Novartis, UCB, AbbVie, Bristol-Myers Squibb, Merck, HEYL Chemisch-pharmazeutische Fabrik, Roche, Johnson & Johnson, Amgen, Pfizer, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Anti-Rheumatic Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Anti-Rheumatic Drugs. The Anti-Rheumatic Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Anti-Rheumatic Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Anti-Rheumatic Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Anti-Rheumatic Drugs Market Report

Report Metric Details
Report Name Anti-Rheumatic Drugs Market
Segment by Type
  • Disease Modifying Anti-rheumatics Drugs (DMARD's)
  • Nonsteroidal Anti-inflammatory Drugs (NSAID's)
  • Corticosteroids
  • Uric Acid Drugs
  • Others
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, UCB, AbbVie, Bristol-Myers Squibb, Merck, HEYL Chemisch-pharmazeutische Fabrik, Roche, Johnson & Johnson, Amgen, Pfizer, GSK, Sanofi, Abbott Laboratories, Teva Pharmaceutical, Eli Lilly and Company, Celltrion, Astellas Pharma, Simcere, Daiichi Sankyo, Asahi Kasei
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Anti-Rheumatic Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-Rheumatic Drugs Market report?

Ans: The main players in the Anti-Rheumatic Drugs Market are Novartis, UCB, AbbVie, Bristol-Myers Squibb, Merck, HEYL Chemisch-pharmazeutische Fabrik, Roche, Johnson & Johnson, Amgen, Pfizer, GSK, Sanofi, Abbott Laboratories, Teva Pharmaceutical, Eli Lilly and Company, Celltrion, Astellas Pharma, Simcere, Daiichi Sankyo, Asahi Kasei

What are the Application segmentation covered in the Anti-Rheumatic Drugs Market report?

Ans: The Applications covered in the Anti-Rheumatic Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Anti-Rheumatic Drugs Market report?

Ans: The Types covered in the Anti-Rheumatic Drugs Market report are Disease Modifying Anti-rheumatics Drugs (DMARD's), Nonsteroidal Anti-inflammatory Drugs (NSAID's), Corticosteroids, Uric Acid Drugs, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Rheumatic Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Disease Modifying Anti-rheumatics Drugs (DMARD's)
1.2.3 Nonsteroidal Anti-inflammatory Drugs (NSAID's)
1.2.4 Corticosteroids
1.2.5 Uric Acid Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Anti-Rheumatic Drugs Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Rheumatic Drugs Market Perspective (2021–2032)
2.2 Global Anti-Rheumatic Drugs Growth Trends by Region
2.2.1 Global Anti-Rheumatic Drugs Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Anti-Rheumatic Drugs Historic Market Size by Region (2021–2026)
2.2.3 Anti-Rheumatic Drugs Forecasted Market Size by Region (2027–2032)
2.3 Anti-Rheumatic Drugs Market Dynamics
2.3.1 Anti-Rheumatic Drugs Industry Trends
2.3.2 Anti-Rheumatic Drugs Market Drivers
2.3.3 Anti-Rheumatic Drugs Market Challenges
2.3.4 Anti-Rheumatic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Rheumatic Drugs Players by Revenue
3.1.1 Global Top Anti-Rheumatic Drugs Players by Revenue (2021–2026)
3.1.2 Global Anti-Rheumatic Drugs Revenue Market Share by Players (2021–2026)
3.2 Global Top Anti-Rheumatic Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Anti-Rheumatic Drugs Revenue
3.4 Global Anti-Rheumatic Drugs Market Concentration Ratio
3.4.1 Global Anti-Rheumatic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Rheumatic Drugs Revenue in 2025
3.5 Global Key Players of Anti-Rheumatic Drugs Head Offices and Areas Served
3.6 Global Key Players of Anti-Rheumatic Drugs, Products and Applications
3.7 Global Key Players of Anti-Rheumatic Drugs, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Anti-Rheumatic Drugs Breakdown Data by Type
4.1 Global Anti-Rheumatic Drugs Historic Market Size by Type (2021–2026)
4.2 Global Anti-Rheumatic Drugs Forecasted Market Size by Type (2027–2032)
5 Anti-Rheumatic Drugs Breakdown Data by Application
5.1 Global Anti-Rheumatic Drugs Historic Market Size by Application (2021–2026)
5.2 Global Anti-Rheumatic Drugs Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Anti-Rheumatic Drugs Market Size (2021–2032)
6.2 North America Anti-Rheumatic Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Anti-Rheumatic Drugs Market Size by Country (2021–2026)
6.4 North America Anti-Rheumatic Drugs Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-Rheumatic Drugs Market Size (2021–2032)
7.2 Europe Anti-Rheumatic Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Anti-Rheumatic Drugs Market Size by Country (2021–2026)
7.4 Europe Anti-Rheumatic Drugs Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Anti-Rheumatic Drugs Market Size (2021–2032)
8.2 Asia-Pacific Anti-Rheumatic Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Anti-Rheumatic Drugs Market Size by Region (2021–2026)
8.4 Asia-Pacific Anti-Rheumatic Drugs Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Anti-Rheumatic Drugs Market Size (2021–2032)
9.2 Latin America Anti-Rheumatic Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Anti-Rheumatic Drugs Market Size by Country (2021–2026)
9.4 Latin America Anti-Rheumatic Drugs Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Rheumatic Drugs Market Size (2021–2032)
10.2 Middle East & Africa Anti-Rheumatic Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Anti-Rheumatic Drugs Market Size by Country (2021–2026)
10.4 Middle East & Africa Anti-Rheumatic Drugs Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Anti-Rheumatic Drugs Introduction
11.1.4 Novartis Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.1.5 Novartis Recent Development
11.2 UCB
11.2.1 UCB Company Details
11.2.2 UCB Business Overview
11.2.3 UCB Anti-Rheumatic Drugs Introduction
11.2.4 UCB Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.2.5 UCB Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Anti-Rheumatic Drugs Introduction
11.3.4 AbbVie Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.3.5 AbbVie Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Anti-Rheumatic Drugs Introduction
11.4.4 Bristol-Myers Squibb Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Anti-Rheumatic Drugs Introduction
11.5.4 Merck Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.5.5 Merck Recent Development
11.6 HEYL Chemisch-pharmazeutische Fabrik
11.6.1 HEYL Chemisch-pharmazeutische Fabrik Company Details
11.6.2 HEYL Chemisch-pharmazeutische Fabrik Business Overview
11.6.3 HEYL Chemisch-pharmazeutische Fabrik Anti-Rheumatic Drugs Introduction
11.6.4 HEYL Chemisch-pharmazeutische Fabrik Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.6.5 HEYL Chemisch-pharmazeutische Fabrik Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Anti-Rheumatic Drugs Introduction
11.7.4 Roche Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.7.5 Roche Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Anti-Rheumatic Drugs Introduction
11.8.4 Johnson & Johnson Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.8.5 Johnson & Johnson Recent Development
11.9 Amgen
11.9.1 Amgen Company Details
11.9.2 Amgen Business Overview
11.9.3 Amgen Anti-Rheumatic Drugs Introduction
11.9.4 Amgen Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.9.5 Amgen Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Anti-Rheumatic Drugs Introduction
11.10.4 Pfizer Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.10.5 Pfizer Recent Development
11.11 GSK
11.11.1 GSK Company Details
11.11.2 GSK Business Overview
11.11.3 GSK Anti-Rheumatic Drugs Introduction
11.11.4 GSK Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.11.5 GSK Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Anti-Rheumatic Drugs Introduction
11.12.4 Sanofi Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.12.5 Sanofi Recent Development
11.13 Abbott Laboratories
11.13.1 Abbott Laboratories Company Details
11.13.2 Abbott Laboratories Business Overview
11.13.3 Abbott Laboratories Anti-Rheumatic Drugs Introduction
11.13.4 Abbott Laboratories Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.13.5 Abbott Laboratories Recent Development
11.14 Teva Pharmaceutical
11.14.1 Teva Pharmaceutical Company Details
11.14.2 Teva Pharmaceutical Business Overview
11.14.3 Teva Pharmaceutical Anti-Rheumatic Drugs Introduction
11.14.4 Teva Pharmaceutical Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.14.5 Teva Pharmaceutical Recent Development
11.15 Eli Lilly and Company
11.15.1 Eli Lilly and Company Company Details
11.15.2 Eli Lilly and Company Business Overview
11.15.3 Eli Lilly and Company Anti-Rheumatic Drugs Introduction
11.15.4 Eli Lilly and Company Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.15.5 Eli Lilly and Company Recent Development
11.16 Celltrion
11.16.1 Celltrion Company Details
11.16.2 Celltrion Business Overview
11.16.3 Celltrion Anti-Rheumatic Drugs Introduction
11.16.4 Celltrion Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.16.5 Celltrion Recent Development
11.17 Astellas Pharma
11.17.1 Astellas Pharma Company Details
11.17.2 Astellas Pharma Business Overview
11.17.3 Astellas Pharma Anti-Rheumatic Drugs Introduction
11.17.4 Astellas Pharma Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.17.5 Astellas Pharma Recent Development
11.18 Simcere
11.18.1 Simcere Company Details
11.18.2 Simcere Business Overview
11.18.3 Simcere Anti-Rheumatic Drugs Introduction
11.18.4 Simcere Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.18.5 Simcere Recent Development
11.19 Daiichi Sankyo
11.19.1 Daiichi Sankyo Company Details
11.19.2 Daiichi Sankyo Business Overview
11.19.3 Daiichi Sankyo Anti-Rheumatic Drugs Introduction
11.19.4 Daiichi Sankyo Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.19.5 Daiichi Sankyo Recent Development
11.20 Asahi Kasei
11.20.1 Asahi Kasei Company Details
11.20.2 Asahi Kasei Business Overview
11.20.3 Asahi Kasei Anti-Rheumatic Drugs Introduction
11.20.4 Asahi Kasei Revenue in Anti-Rheumatic Drugs Business (2021–2026)
11.20.5 Asahi Kasei Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Novartis
UCB
AbbVie
Bristol–Myers Squibb
Merck
HEYL Chemisch-pharmazeutische Fabrik
Roche
Johnson & Johnson
Amgen Inc
Pfizer Inc
GSK
Sanofi
Abbott Laboratories
Teva Pharmaceutical
Eli Lilly and Company
Celltrion
Astellas Pharma
Simcere
Daiichi Sankyo
Asahi Kasei
Johnson & Johnson
List of Tables
 Table 1. Global Anti-Rheumatic Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Disease Modifying Anti-rheumatics Drugs (DMARD's)
 Table 3. Key Players of Nonsteroidal Anti-inflammatory Drugs (NSAID's)
 Table 4. Key Players of Corticosteroids
 Table 5. Key Players of Uric Acid Drugs
 Table 6. Key Players of Others
 Table 7. Global Anti-Rheumatic Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Anti-Rheumatic Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 9. Global Anti-Rheumatic Drugs Market Size by Region (US$ Million), 2021–2026
 Table 10. Global Anti-Rheumatic Drugs Market Share by Region (2021–2026)
 Table 11. Global Anti-Rheumatic Drugs Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 12. Global Anti-Rheumatic Drugs Market Share by Region (2027–2032)
 Table 13. Anti-Rheumatic Drugs Market Trends
 Table 14. Anti-Rheumatic Drugs Market Drivers
 Table 15. Anti-Rheumatic Drugs Market Challenges
 Table 16. Anti-Rheumatic Drugs Market Restraints
 Table 17. Global Anti-Rheumatic Drugs Revenue by Players (US$ Million), 2021–2026
 Table 18. Global Anti-Rheumatic Drugs Market Share by Players (2021–2026)
 Table 19. Global Top Anti-Rheumatic Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Anti-Rheumatic Drugs Revenue, 2025
 Table 20. Ranking of Global Top Anti-Rheumatic Drugs Companies by Revenue (US$ Million) in 2025
 Table 21. Global 5 Largest Players Market Share by Anti-Rheumatic Drugs Revenue (CR5 and HHI), 2021–2026
 Table 22. Global Key Players of Anti-Rheumatic Drugs, Headquarters and Area Served
 Table 23. Global Key Players of Anti-Rheumatic Drugs, Products and Applications
 Table 24. Global Key Players of Anti-Rheumatic Drugs, Date of General Availability (GA)
 Table 25. Mergers and Acquisitions, Expansion Plans
 Table 26. Global Anti-Rheumatic Drugs Market Size by Type (US$ Million), 2021–2026
 Table 27. Global Anti-Rheumatic Drugs Revenue Market Share by Type (2021–2026)
 Table 28. Global Anti-Rheumatic Drugs Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 29. Global Anti-Rheumatic Drugs Revenue Market Share by Type (2027–2032)
 Table 30. Global Anti-Rheumatic Drugs Market Size by Application (US$ Million), 2021–2026
 Table 31. Global Anti-Rheumatic Drugs Revenue Market Share by Application (2021–2026)
 Table 32. Global Anti-Rheumatic Drugs Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 33. Global Anti-Rheumatic Drugs Revenue Market Share by Application (2027–2032)
 Table 34. North America Anti-Rheumatic Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. North America Anti-Rheumatic Drugs Market Size by Country (US$ Million), 2021–2026
 Table 36. North America Anti-Rheumatic Drugs Market Size by Country (US$ Million), 2027–2032
 Table 37. Europe Anti-Rheumatic Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Europe Anti-Rheumatic Drugs Market Size by Country (US$ Million), 2021–2026
 Table 39. Europe Anti-Rheumatic Drugs Market Size by Country (US$ Million), 2027–2032
 Table 40. Asia-Pacific Anti-Rheumatic Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Asia-Pacific Anti-Rheumatic Drugs Market Size by Region (US$ Million), 2021–2026
 Table 42. Asia-Pacific Anti-Rheumatic Drugs Market Size by Region (US$ Million), 2027–2032
 Table 43. Latin America Anti-Rheumatic Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Latin America Anti-Rheumatic Drugs Market Size by Country (US$ Million), 2021–2026
 Table 45. Latin America Anti-Rheumatic Drugs Market Size by Country (US$ Million), 2027–2032
 Table 46. Middle East & Africa Anti-Rheumatic Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 47. Middle East & Africa Anti-Rheumatic Drugs Market Size by Country (US$ Million), 2021–2026
 Table 48. Middle East & Africa Anti-Rheumatic Drugs Market Size by Country (US$ Million), 2027–2032
 Table 49. Novartis Company Details
 Table 50. Novartis Business Overview
 Table 51. Novartis Anti-Rheumatic Drugs Product
 Table 52. Novartis Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 53. Novartis Recent Development
 Table 54. UCB Company Details
 Table 55. UCB Business Overview
 Table 56. UCB Anti-Rheumatic Drugs Product
 Table 57. UCB Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 58. UCB Recent Development
 Table 59. AbbVie Company Details
 Table 60. AbbVie Business Overview
 Table 61. AbbVie Anti-Rheumatic Drugs Product
 Table 62. AbbVie Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 63. AbbVie Recent Development
 Table 64. Bristol-Myers Squibb Company Details
 Table 65. Bristol-Myers Squibb Business Overview
 Table 66. Bristol-Myers Squibb Anti-Rheumatic Drugs Product
 Table 67. Bristol-Myers Squibb Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 68. Bristol-Myers Squibb Recent Development
 Table 69. Merck Company Details
 Table 70. Merck Business Overview
 Table 71. Merck Anti-Rheumatic Drugs Product
 Table 72. Merck Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 73. Merck Recent Development
 Table 74. HEYL Chemisch-pharmazeutische Fabrik Company Details
 Table 75. HEYL Chemisch-pharmazeutische Fabrik Business Overview
 Table 76. HEYL Chemisch-pharmazeutische Fabrik Anti-Rheumatic Drugs Product
 Table 77. HEYL Chemisch-pharmazeutische Fabrik Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 78. HEYL Chemisch-pharmazeutische Fabrik Recent Development
 Table 79. Roche Company Details
 Table 80. Roche Business Overview
 Table 81. Roche Anti-Rheumatic Drugs Product
 Table 82. Roche Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 83. Roche Recent Development
 Table 84. Johnson & Johnson Company Details
 Table 85. Johnson & Johnson Business Overview
 Table 86. Johnson & Johnson Anti-Rheumatic Drugs Product
 Table 87. Johnson & Johnson Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 88. Johnson & Johnson Recent Development
 Table 89. Amgen Company Details
 Table 90. Amgen Business Overview
 Table 91. Amgen Anti-Rheumatic Drugs Product
 Table 92. Amgen Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 93. Amgen Recent Development
 Table 94. Pfizer Company Details
 Table 95. Pfizer Business Overview
 Table 96. Pfizer Anti-Rheumatic Drugs Product
 Table 97. Pfizer Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 98. Pfizer Recent Development
 Table 99. GSK Company Details
 Table 100. GSK Business Overview
 Table 101. GSK Anti-Rheumatic Drugs Product
 Table 102. GSK Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 103. GSK Recent Development
 Table 104. Sanofi Company Details
 Table 105. Sanofi Business Overview
 Table 106. Sanofi Anti-Rheumatic Drugs Product
 Table 107. Sanofi Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 108. Sanofi Recent Development
 Table 109. Abbott Laboratories Company Details
 Table 110. Abbott Laboratories Business Overview
 Table 111. Abbott Laboratories Anti-Rheumatic Drugs Product
 Table 112. Abbott Laboratories Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 113. Abbott Laboratories Recent Development
 Table 114. Teva Pharmaceutical Company Details
 Table 115. Teva Pharmaceutical Business Overview
 Table 116. Teva Pharmaceutical Anti-Rheumatic Drugs Product
 Table 117. Teva Pharmaceutical Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 118. Teva Pharmaceutical Recent Development
 Table 119. Eli Lilly and Company Company Details
 Table 120. Eli Lilly and Company Business Overview
 Table 121. Eli Lilly and Company Anti-Rheumatic Drugs Product
 Table 122. Eli Lilly and Company Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 123. Eli Lilly and Company Recent Development
 Table 124. Celltrion Company Details
 Table 125. Celltrion Business Overview
 Table 126. Celltrion Anti-Rheumatic Drugs Product
 Table 127. Celltrion Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 128. Celltrion Recent Development
 Table 129. Astellas Pharma Company Details
 Table 130. Astellas Pharma Business Overview
 Table 131. Astellas Pharma Anti-Rheumatic Drugs Product
 Table 132. Astellas Pharma Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 133. Astellas Pharma Recent Development
 Table 134. Simcere Company Details
 Table 135. Simcere Business Overview
 Table 136. Simcere Anti-Rheumatic Drugs Product
 Table 137. Simcere Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 138. Simcere Recent Development
 Table 139. Daiichi Sankyo Company Details
 Table 140. Daiichi Sankyo Business Overview
 Table 141. Daiichi Sankyo Anti-Rheumatic Drugs Product
 Table 142. Daiichi Sankyo Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 143. Daiichi Sankyo Recent Development
 Table 144. Asahi Kasei Company Details
 Table 145. Asahi Kasei Business Overview
 Table 146. Asahi Kasei Anti-Rheumatic Drugs Product
 Table 147. Asahi Kasei Revenue in Anti-Rheumatic Drugs Business (US$ Million), 2021–2026
 Table 148. Asahi Kasei Recent Development
 Table 149. Research Programs/Design for This Report
 Table 150. Key Data Information from Secondary Sources
 Table 151. Key Data Information from Primary Sources
 Table 152. Authors List of This Report


List of Figures
 Figure 1. Anti-Rheumatic Drugs Picture
 Figure 2. Global Anti-Rheumatic Drugs Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Anti-Rheumatic Drugs Market Share by Type: 2025 vs 2032
 Figure 4. Disease Modifying Anti-rheumatics Drugs (DMARD's) Features
 Figure 5. Nonsteroidal Anti-inflammatory Drugs (NSAID's) Features
 Figure 6. Corticosteroids Features
 Figure 7. Uric Acid Drugs Features
 Figure 8. Others Features
 Figure 9. Global Anti-Rheumatic Drugs Market Size by Application (US$ Million), 2021–2032
 Figure 10. Global Anti-Rheumatic Drugs Market Share by Application: 2025 vs 2032
 Figure 11. Hospital Pharmacies Case Studies
 Figure 12. Retail Pharmacies Case Studies
 Figure 13. Online Pharmacies Case Studies
 Figure 14. Anti-Rheumatic Drugs Report Years Considered
 Figure 15. Global Anti-Rheumatic Drugs Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 16. Global Anti-Rheumatic Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Anti-Rheumatic Drugs Market Share by Region: 2025 vs 2032
 Figure 18. Global Anti-Rheumatic Drugs Market Share by Players in 2025
 Figure 19. Global Anti-Rheumatic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 20. The Top 10 and 5 Players Market Share by Anti-Rheumatic Drugs Revenue in 2025
 Figure 21. North America Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. North America Anti-Rheumatic Drugs Market Share by Country (2021–2032)
 Figure 23. United States Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Canada Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Europe Anti-Rheumatic Drugs Market Share by Country (2021–2032)
 Figure 27. Germany Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. France Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. U.K. Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Italy Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Russia Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Ireland Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Asia-Pacific Anti-Rheumatic Drugs Market Share by Region (2021–2032)
 Figure 35. China Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Japan Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. South Korea Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Southeast Asia Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. India Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Australia & New Zealand Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Latin America Anti-Rheumatic Drugs Market Share by Country (2021–2032)
 Figure 43. Mexico Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Brazil Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Middle East & Africa Anti-Rheumatic Drugs Market Share by Country (2021–2032)
 Figure 47. Israel Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Saudi Arabia Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. UAE Anti-Rheumatic Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Novartis Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 51. UCB Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 52. AbbVie Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 54. Merck Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 55. HEYL Chemisch-pharmazeutische Fabrik Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 56. Roche Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 57. Johnson & Johnson Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 58. Amgen Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 59. Pfizer Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 60. GSK Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 61. Sanofi Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 62. Abbott Laboratories Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 63. Teva Pharmaceutical Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 64. Eli Lilly and Company Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 65. Celltrion Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 66. Astellas Pharma Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 67. Simcere Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 68. Daiichi Sankyo Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 69. Asahi Kasei Revenue Growth Rate in Anti-Rheumatic Drugs Business (2021–2026)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Rheumatoid Arthritis RA Medications Market Research Report 2025
Global Antirheumatics Pharmaceutical Market Insights Forecast to 2030
Global Rheumatoid Arthritis Medicine Market Research Report 2025
Global Musculoskeletal System Disorder Drug Market Research Report 2024
Rheumatic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Autoimmune Disease Drugs Market Research Report 2025
Global Antiinflammatory Drugs Market Insights Forecast to 2030
Global Disease Modifying Antirheumatic Drug Market Insights Forecast to 2030
Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025
Global Anti inflammatory Agents Market Research Report 2024
Rheumatic Heart Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rheumatic Disorders Drug Market Insights Forecast to 2030
Rheumatology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lupus Therapeutic Market Research Report 2024
Global Anti allergic Drugs Market Research Report 2025
Global Systemic Autoinflammatory Diseases Drug Market Research Report 2024
Rheumatoid Arthritis RA Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rheumatoid Arthritis and Lupus Treatments Market Research Report 2024
Anti inflammatory Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antigout Drug Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions